The news followed an investigation by POLITICO's E&E News into climate-friendly inhalers and how drug giants are developing ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...

Americans with asthma and 16 million Americans with COPD need inhalers to breathe. Vermont Business Magazine Sen. Bernie Sanders (I-Vermont), Chairman of the Senate Com ...

Why are the inhalers being discontinued? A spokeswoman for GSK told the Asthma and Allergy Foundation of America that the company is making the change to provide U.S. patients “with potentially ...

Having begun working together in December 2015, the partners are now ready to bring to market their custom digital sensor for GSK’s asthma and COPD inhaler, Ellipta. The sensor attaches to the ...

Generic inhalers can cost as little as $30. Notably, GSK said it recently reduced the list price of Advair HFA by an average ...

Efforts to supplant pressurised metered-dose inhalers (pMDIs) with DPIs, most recently by the European Network on Climate and Health Education (ENCHE), have gained steam in recent years. Companies ...

A global leader in pharmaceuticals, GSK’s mechanical engineers are responsible for projects from the design and installation of manufacturing equipment through to building maintenance and R&D. As ...

GSK declined to "comment on legal matters faced ... General's concern about the opioid crisis" and that its "opioid medications account for less than 2% of total opioid prescriptions".